Order Article Reprints

Tsiogka A, Gregoriou S, Stratigos A, Soulaidopoulos S, Rompoti N, Panagakis P, Papoutsaki M, Kostakis P, Kontochristopoulos G, Tsioufis K, et al. The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review. Biomedicines. 2023; 11(2):318. https://doi.org/10.3390/biomedicines11020318

Tsiogka, Aikaterini, Stamatios Gregoriou, Alexander Stratigos, Stergios Soulaidopoulos, Natalia Rompoti, Pantelis Panagakis, Marina Papoutsaki, Panagiotis Kostakis, George Kontochristopoulos, Konstantinos Tsioufis, and et al. 2023. "The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review" Biomedicines 11, no. 2: 318. https://doi.org/10.3390/biomedicines11020318

Tsiogka, A., Gregoriou, S., Stratigos, A., Soulaidopoulos, S., Rompoti, N., Panagakis, P., Papoutsaki, M., Kostakis, P., Kontochristopoulos, G., Tsioufis, K., Campanati, A., Offidani, A., Vlachopoulos, C., & Rigopoulos, D. (2023). The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review. Biomedicines, 11(2), 318. https://doi.org/10.3390/biomedicines11020318